Ingenza factor VIII production process moves transformative haemophilia A treatment closer to clinical trials

Ingenza has reached an important milestone in its work to develop a low cost recombinant human factor VIII (rhFVIII) production process to make materials for ProFactor Pharma Ltd (PFP). The goal of this work is to enable PFP to transform…